NIAID seeks 1 million volunteers for COVID-19 vaccine trials Sponsored by Oracle
Ultimately, as many as five Phase 3 trials—the others not involving Moderna—will be carried out, each of them requiring 30,000 participants. To get there, NIAID will need to enlist at least a million people for consideration.
Participants in a July 27 news conference on the Phase 3 clinical trial. Pictured clockwise are NIAID Director Anthony S. Fauci, NIH Director Francis Collins, Moderna President Stephen Hoge, and a trial volunteer identified only as Robyn.Results from smaller, earlier-stage clinical tests indicate that the vaccine under evaluation, called mRNA-1273, is safe, thus supporting the more extensive Phase 3 trial, said Dr.
On a July 27 online news conference, NIH Director Dr. Francis Collins noted the unprecedented speed of the COVID-19 trial process so far—just 65 days from knowing the sequence of the virus’s RNA to injecting the first patient with the candidate vaccine as part of the 45-person Phase 1 trial, then just four months from Phase 1 to Phase 3.
Within a month, patients come back for a booster shot and then are asked to go about their normal lives, adhering to the standard public health guidance on social distancing, wearing masks, and other preventative measures, before coming back for routine lab tests to determine if they’ve been infected or not.
Key to the trial is determining whether there’s an imbalance between the number of people who were infected with the virus after receiving the placebo versus those who got infected after receiving the vaccine, Dr. Hoge said.Even as NIAID and Moderna work to recruit the 30,000 people they need for their Phase 3 trial, that trial has already begun, with the first participant given the candidate vaccine at 6:45 a.m. on July 27.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Vaccine Candidate Delivers Protection In A Single Shot (In Monkeys)Two new studies involving monkeys suggest COVID-19 vaccine candidates can provide disease protection after a single injection — but it will take large-scale human trials to know for sure if they work.
Read more »
'Vaccine nationalism': Is it every country for itself?A slew of bilateral deals between governments and drugmakers to secure millions of doses of COVID-19 vaccines is putting at risk a WHO co-led initiative to bulk-buy and equitably distribute the pandemic vaccines around the world
Read more »
J&J starts human study of COVID-19 vaccine after promising monkey dataWhen exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study published in the journal Nature. 'This gives
Read more »
Coronavirus updates: NJ sees 112% increase in cases, deaths double in Atlanta areaLATEST: Ohio Board of Pharmacy withdraws its new rule prohibiting the sale or distribution of hydroxychloroquine for COVID-19 after facing opposition from Ohio Gov. Mike DeWine.
Read more »
Coronavirus updates: 150,000 dead in USCORONAVIRUS LATEST: — Florida and Texas see deadliest days since start of pandemic. — New Jersey counties re-emerging as 'hot spots.' — Alabama, Maryland enforce new mask mandates.
Read more »
Coronavirus updates: Global cases of COVID-19 surge by more than 2 million in just 8 daysCORONAVIRUS LATEST: • Globally, there are now more than 17 million confirmed cases of COVID-19, per John Hopkins University tally. • Pandemic has killed more than 664,000 people across the globe.
Read more »